{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T21:47:41Z","timestamp":1778276861249,"version":"3.51.4"},"reference-count":31,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Diagnostic Pathology"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1053\/j.semdp.2020.01.002","type":"journal-article","created":{"date-parts":[[2020,2,6]],"date-time":"2020-02-06T11:39:37Z","timestamp":1580989177000},"page":"121-126","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["A New Paradigm for Renal Thrombotic Microangiopathy"],"prefix":"10.1053","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3180-6133","authenticated-orcid":false,"given":"Alexander J.","family":"Gallan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6877-5510","authenticated-orcid":false,"given":"Anthony","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1053\/j.semdp.2020.01.002_bib0001","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/nrneph.2016.70","article-title":"Complement in disease: a defence system turning offensive","volume":"12","author":"Ricklin","year":"2016","journal-title":"Nat Rev Nephrol"},{"issue":"10","key":"10.1053\/j.semdp.2020.01.002_bib0002","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.2215\/CJN.02210310","article-title":"Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype","volume":"5","author":"Noris","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"issue":"10","key":"10.1053\/j.semdp.2020.01.002_bib0003","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1182\/blood-2017-04-636431","article-title":"Pathophysiology of thrombotic thrombocytopenic purpura","volume":"130","author":"Sadler","year":"2017","journal-title":"Blood"},{"issue":"10","key":"10.1053\/j.semdp.2020.01.002_bib0004","doi-asserted-by":"crossref","first-page":"6394","DOI":"10.4049\/jimmunol.0900151","article-title":"Shiga toxin activates complement and binds factor H: evidence for an active role of complement in hemolytic uremic syndrome","volume":"182","author":"Orth","year":"2009","journal-title":"J Immunol"},{"issue":"4","key":"10.1053\/j.semdp.2020.01.002_bib0005","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.kint.2016.05.011","article-title":"Human mannose-binding lectin inhibitor prevents Shiga toxin-induced renal injury","volume":"90","author":"Ozaki","year":"2016","journal-title":"Kidney Int"},{"issue":"10","key":"10.1053\/j.semdp.2020.01.002_bib0006","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1182\/blood-2011-02-339564","article-title":"beta(2)-glycoprotein I, the major target in antiphospholipid syndrome, is a special human complement regulator","volume":"118","author":"Gropp","year":"2011","journal-title":"Blood"},{"issue":"11","key":"10.1053\/j.semdp.2020.01.002_bib0007","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1172\/JCI200318817","article-title":"Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome","volume":"112","author":"Girardi","year":"2003","journal-title":"J Clin Invest"},{"issue":"8","key":"10.1053\/j.semdp.2020.01.002_bib0008","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1681\/ASN.2007020255","article-title":"The glomerular injury of preeclampsia","volume":"18","author":"Stillman","year":"2007","journal-title":"J Am Soc Nephrol"},{"issue":"11","key":"10.1053\/j.semdp.2020.01.002_bib0009","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1056\/NEJMoa0707330","article-title":"VEGF inhibition and renal thrombotic microangiopathy","volume":"358","author":"Eremina","year":"2008","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1053\/j.semdp.2020.01.002_bib0010","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1172\/JCI86418","article-title":"VEGF regulates local inhibitory complement proteins in the eye and kidney","volume":"127","author":"Keir","year":"2017","journal-title":"J Clin Invest"},{"issue":"5","key":"10.1053\/j.semdp.2020.01.002_bib0011","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.exphem.2016.01.005","article-title":"Direct evidence of complement activation in HELLP syndrome: a link to atypical hemolytic uremic syndrome","volume":"44","author":"Vaught","year":"2016","journal-title":"Exp Hematol"},{"issue":"5","key":"10.1053\/j.semdp.2020.01.002_bib0012","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1681\/ASN.2009070706","article-title":"Pregnancy-associated hemolytic uremic syndrome revisited in the era of complement gene mutations","volume":"21","author":"Fakhouri","year":"2010","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"10.1053\/j.semdp.2020.01.002_bib0013","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.kint.2016.12.009","article-title":"Patients with hypertension-associated thrombotic microangiopathy may present with complement abnormalities","volume":"91","author":"Timmermans","year":"2017","journal-title":"Kidney Int"},{"key":"10.1053\/j.semdp.2020.01.002_bib0014","unstructured":"Zuckerman JE and Chang A. Complement and renal thrombotic microangiopathy associated with hypertension and scleroderma. Adv Chronic Kidney Dis. (In press)."},{"issue":"3","key":"10.1053\/j.semdp.2020.01.002_bib0015","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.humpath.2008.08.001","article-title":"Renal biopsy findings predicting outcome in scleroderma renal crisis","volume":"40","author":"Batal","year":"2009","journal-title":"Hum Pathol"},{"issue":"1","key":"10.1053\/j.semdp.2020.01.002_bib0016","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1186\/s13075-016-1168-x","article-title":"Analysis of complement biomarkers in systemic sclerosis indicates a distinct pattern in scleroderma renal crisis","volume":"18","author":"Okroj","year":"2016","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"10.1053\/j.semdp.2020.01.002_bib0017","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.semnephrol.2013.08.003","article-title":"Atypical hemolytic uremic syndrome","volume":"33","author":"Kavanagh","year":"2013","journal-title":"Semin Nephrol"},{"issue":"2","key":"10.1053\/j.semdp.2020.01.002_bib0018","doi-asserted-by":"crossref","first-page":"300","DOI":"10.2215\/CJN.00620117","article-title":"Thrombotic Microangiopathy and the Kidney","volume":"13","author":"Brocklebank","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.semdp.2020.01.002_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.tmrv.2019.09.004","article-title":"Eculizumab and beyond: the past, present, and future of complement therapeutics","author":"Patriquin","year":"2019","journal-title":"Transfus Med Rev"},{"issue":"7","key":"10.1053\/j.semdp.2020.01.002_bib0020","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1038\/sj.ki.5000234","article-title":"Sickle cell disease, nephrotic syndrome, and renal failure","volume":"69","author":"Nasr","year":"2006","journal-title":"Kidney Int"},{"issue":"7","key":"10.1053\/j.semdp.2020.01.002_bib0021","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.humpath.2010.09.013","article-title":"Intragraft vascular occlusive sickle crisis with early renal allograft loss in occult sickle cell trait","volume":"42","author":"Kim","year":"2011","journal-title":"Hum Pathol"},{"issue":"8","key":"10.1053\/j.semdp.2020.01.002_bib0022","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1055\/s-0032-1328886","article-title":"Drug-associated thrombotic microangiopathies","volume":"38","author":"Kreuter","year":"2012","journal-title":"Semin Thromb Hemost"},{"issue":"5","key":"10.1053\/j.semdp.2020.01.002_bib0023","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.2215\/CJN.01700407","article-title":"Spectrum of renal pathology in hematopoietic cell transplantation: a series of 20 patients and review of the literature","volume":"2","author":"Chang","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"issue":"18","key":"10.1053\/j.semdp.2020.01.002_bib0024","doi-asserted-by":"crossref","first-page":"5858","DOI":"10.1158\/1078-0432.CCR-11-0804","article-title":"Thrombotic microangiopathy with targeted cancer agents","volume":"17","author":"Blake-Haskins","year":"2011","journal-title":"Clin Cancer Res"},{"issue":"11","key":"10.1053\/j.semdp.2020.01.002_bib0025","doi-asserted-by":"crossref","first-page":"3519","DOI":"10.1111\/trf.15534","article-title":"Approaching treatment of transplant-associated thrombotic Microangiopathy from two directions with Eculizumab and transitioning from Tacrolimus to Sirolimus","volume":"59","author":"Jan","year":"2019","journal-title":"Transfusion"},{"issue":"3","key":"10.1053\/j.semdp.2020.01.002_bib0026","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/MOT.0000000000000074","article-title":"Thrombotic microangiopathy in renal allografts: the diagnostic challenge","volume":"19","author":"Nadasdy","year":"2014","journal-title":"Curr Opin Organ Transplant"},{"issue":"10","key":"10.1053\/j.semdp.2020.01.002_bib0027","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1038\/bmt.2017.39","article-title":"Transplant-associated thrombotic microangiopathy: opening Pandora's box","volume":"52","author":"Gavriilaki","year":"2017","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"10.1053\/j.semdp.2020.01.002_bib0028","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/j.kint.2016.07.021","article-title":"Collapsing glomerulopathy is common in the setting of thrombotic microangiopathy of the native kidney","volume":"90","author":"Buob","year":"2016","journal-title":"Kidney Int"},{"issue":"6","key":"10.1053\/j.semdp.2020.01.002_bib0029","doi-asserted-by":"crossref","first-page":"397","DOI":"10.5414\/CNP66397","article-title":"A clinicopathologic study of thrombotic microangiopathy in the setting of IgA nephropathy","volume":"66","author":"Chang","year":"2006","journal-title":"Clin Nephrol"},{"issue":"1","key":"10.1053\/j.semdp.2020.01.002_bib0030","doi-asserted-by":"crossref","first-page":"R12","DOI":"10.1186\/ar4142","article-title":"The spectrum of renal thrombotic microangiopathy in lupus nephritis","volume":"15","author":"Song","year":"2013","journal-title":"Arthritis Res Ther"},{"issue":"8","key":"10.1053\/j.semdp.2020.01.002_bib0031","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.mayocp.2018.05.019","article-title":"C3 glomerulopathy: ten years' experience at mayo clinic","volume":"93","author":"Ravindran","year":"2018","journal-title":"Mayo Clin Proc"}],"container-title":["Seminars in Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740257020300083?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740257020300083?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:20:53Z","timestamp":1760037653000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740257020300083"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S0740257020300083"],"URL":"https:\/\/doi.org\/10.1053\/j.semdp.2020.01.002","relation":{},"ISSN":["0740-2570"],"issn-type":[{"value":"0740-2570","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A New Paradigm for Renal Thrombotic Microangiopathy","name":"articletitle","label":"Article Title"},{"value":"Seminars in Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.semdp.2020.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}